SECsense Logo

AngioDynamics, Inc. 8-K Filing Report: Key Updates for Investors

$ANGO
Form 8-K
Filed on: 2025-01-08
Source
AngioDynamics, Inc. 8-K Filing Report: Key Updates for Investors

Here are the key details extracted from the provided financial report section:

  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: January 8, 2025
  1. Company Information:
  • Company Name: AngioDynamics, Inc.
  • Company CIK: 0001275187
  • Company IRS Employer Identification Number (EIN): 11-3146460
  • State of Incorporation: Delaware (DE)
  • Company Address: 14 Plaza Drive, Latham, NY 12110
  • Phone Number: 518-795-1400
  1. Ticker Symbol:
  • Common Stock Ticker: ANGO
  • Exchange: NASDAQ
  1. Stock Information:
  • Par Value: $0.01 per share
  1. Context Information:
  • Period: The reporting period starts and ends on January 8, 2025.

Insights:

  • The filing is a Form 8-K, which typically indicates that the company is reporting a significant event that shareholders should be aware of. This could include events such as acquisitions, changes in management, or other material events.
  • The report is specific to AngioDynamics, which operates in the medical device sector, suggesting that any significant events reported could be related to advancements in medical technology or regulatory updates.
  • The filing is dated early in the year (January 8), which may indicate that it could relate to year-end activities or strategic initiatives for the upcoming year.

This information is crucial for investors or analysts who monitor AngioDynamics for potential impacts on stock performance or business strategy changes.